Pure Global

Effect of Acupuncture on the Microbiota-gut-brain Axis in Crohn's Disease - Trial NCT06364722

Access comprehensive clinical trial information for NCT06364722 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai Institute of Acupuncture, Moxibustion and Meridian and is currently Completed. The study focuses on Crohn Disease. Target enrollment is 64 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06364722
Completed
other
Trial Details
ClinicalTrials.gov โ€ข NCT06364722
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effect of Acupuncture on the Microbiota-gut-brain Axis in Crohn's Disease

Study Focus

Crohn Disease

Acupuncture treatment

Interventional

other

Sponsor & Location

Shanghai Institute of Acupuncture, Moxibustion and Meridian

Timeline & Enrollment

N/A

May 01, 2015

Mar 28, 2024

64 participants

Primary Outcome

Effect of Acupuncture on Crohn's Disease Activity Index (CDAI)

Summary

Multidisciplinary techniques such as multimodal neuroimaging, microbiology, and
 bioinformatics were applied to study the differences in correlation characteristics between
 gut microbes, functional brain networks, and peripheral inflammation among patients with
 active Crohn's disease (CD), CD in remission, and healthy subjects.

ICD-10 Classifications

Crohn disease, unspecified
Other Crohn disease
Crohn disease of large intestine
Crohn disease of small intestine
Crohn disease [regional enteritis]

Data Source

ClinicalTrials.gov

NCT06364722

Non-Device Trial